Skip to main content

Advertisement

Log in

Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Goal of work

The aim of the study is to evaluate the effect of fluconazole antifungal prophylaxis on the severity of mucositis in head and neck cancer patients receiving radiotherapy.

Patients and methods

Sixty-three patients, with malignant head and neck tumor, eligible to receive radiotherapy, entered the study. Thirty-four patients (group A) received 100 mg/day of fluconazole prophylaxis during radiotherapy and were compared with 29 patients, who received radiotherapy alone (group B). The two groups were similar in terms of patients and radiotherapy characteristics. Smear to test for Candida carriage was taken before and after radiotherapy. Oral candidiasis was diagnosed using the criteria described before. Oral mucositis was recorded according to EORTC/RTOG criteria.

Main results

A significant reduction of severe mucositis at the end of radiotherapy (14.7 vs 44.8%, p=0.018) and of interruptions (0 vs 17.2%, p=0.017) was observed in group A. Candidiasis was prevented (0 vs 34.5%, p=0.001), with a significant reduction of Candida carriage of 40.7% (p=0.001).

Conclusion

Fluconazole prophylaxis showed a significant beneficial impact on the severity of mucositis and on radiotherapy interruptions in this group of patients. The current study provides data on the build of a randomized controlled trial on the effect of fluconazole prophylaxis on treatment schedule and quality of life of the patients during head and neck radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Arendorf TM, Walker DM (1980) The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 25:1–10

    Article  CAS  PubMed  Google Scholar 

  2. Chen TY, Webster JH (1974) Oral Monilia study on patients with head and neck cancer during radiotherapy. Cancer 34:246–249

    Google Scholar 

  3. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346

    Article  CAS  PubMed  Google Scholar 

  4. Dahiya MC, Redding SW, Dahiya RS et al (2003) Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head–neck cancer. Int J Radiat Oncol Biol Phys 57:79–83

    Article  PubMed  Google Scholar 

  5. El-Sayed S, Nabid A, Shelley W et al (2002) Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. J Clin Oncol 20:3956–3963

    Article  CAS  PubMed  Google Scholar 

  6. Epstein JB, Freilich MM, Nhu DL (1993) Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 76:169–174

    CAS  PubMed  Google Scholar 

  7. Koc M, Aktas E (2003) Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck tumors. Jpn J Clin Oncol 33:57–60

    Article  PubMed  Google Scholar 

  8. Kollia K, Arabatzis M, Kostoula O et al (2003) Clavispora (Candida) lusitaniae susceptibility profiles and genetic diversity in three tertiary hospitals (1998–2001). Int J Antimicrob Agents 22:455–457

    Google Scholar 

  9. Kwong DLW, Sham JST, Chua DTT, Choy DTK, Au GKU, Wu PM (1997) The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 39:703–710

    Article  CAS  PubMed  Google Scholar 

  10. Makkonen TA, Minn H, Jekunen A, Vilja P, Tuominen J, Joensuu H (2000) Granulocyte-macrophage colony-stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study. Int J Radiat Oncol Biol Phys 46:525–534

    Article  CAS  PubMed  Google Scholar 

  11. Martin MV, Al-Tikriti U, Bramley PA (1981) Yeast flora of the mouth and skin during and after irradiation for oral and laryngeal cancer. J Med Microbiol 14:457–467

    CAS  PubMed  Google Scholar 

  12. Mucke R, Kaben U, Libera T et al (1998) Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy. Mycoses 41:421–423

    CAS  PubMed  Google Scholar 

  13. Nicolatou O, Sotiropoulou-Lontou A, Skarlatos J, Kyprianou K, Kolitsi G, Dardoufas K (1998) A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy : a preliminary report. Int J Radiat Oncol Biol Phys 42:551–556

    Article  CAS  PubMed  Google Scholar 

  14. Nicolatou-Galitis O, Dardoufas K, Markoulatos P et al (2001) Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. J Oral Pathol Med 30:471–480

    Google Scholar 

  15. Nicolatou-Galitis O, Sotiropoulou-Lontou A, Velegraki A et al (2003) Oral candidiasis in head and neck cancer patients receiving radiotherapy, with amifostine cytoprotection. Oral Oncol 39:397–401

    Article  CAS  PubMed  Google Scholar 

  16. Paula CR, Sampaio MCC, Birman EG, Siqueira AM (1990) Oral yeasts in patients with cancer of the mouth, before and during radiotherapy. Mycopathologia 112:119–124

    Article  CAS  PubMed  Google Scholar 

  17. Redding SW, Zellars RC, Kirkpatrick WR et al (1999) Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 37:3896–3900

    CAS  PubMed  Google Scholar 

  18. Rossie KM, Taylor J, Beck FM, Hodson SE, Blozis GG (1987) Influence of radiation therapy on oral Candida albicans colonization: a quantitative assessment. Oral Surg Oral Med Oral Pathol 64:698–701

    CAS  PubMed  Google Scholar 

  19. Samaranayake LP, MacFarlane TW (1990) Oral candidosis. Wright, London, p 7

    Google Scholar 

  20. Sebti A, Kiehn TE, Perlin D et al (2001) Candida dubliniensis at a Cancer Center. CID 32:1034–1038

    Article  CAS  Google Scholar 

  21. Sonis ST (2004) A biological approach to mucositis. J Support Oncol 2:21–36

    PubMed  Google Scholar 

  22. Spijkervet FKL, van Saene HKF, Panders AK, Vermey A, Mehta DM (1989) Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med 18:167–171

    CAS  PubMed  Google Scholar 

  23. Spijkervet FKL, van Saene HKF, van Saene JJM et al (1991) Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients. J Surg Oncol 46:167–173

    CAS  PubMed  Google Scholar 

  24. Trotti A, Bellm LA, Epstein JB et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy : a systematic literature review. Radiother Oncol 66:253–262

    Article  PubMed  Google Scholar 

  25. Wijers OB, Levendag PC, Harms ERE et al (2001) Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys 50:343–352

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The reagents for the mycology laboratory investigation were kindly donated by Pfizer Hellas.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ourania Nicolatou-Galitis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nicolatou-Galitis, O., Velegraki, A., Sotiropoulou-Lontou, A. et al. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Support Care Cancer 14, 44–51 (2006). https://doi.org/10.1007/s00520-005-0835-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-005-0835-2

Keywords

Navigation